Clinical trial
Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate…
NCT00005075 · EDAP Technomed, Industry · Terminated
Key facts
| NCT number | NCT00005075 |
|---|---|
| Title | Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer |
| Official title | Evaluation of the Ablatherm High Intensity Focused Ultrasound Device After Failed Radiation Therapy for Localized Prostate Cancer |
| Lead sponsor | EDAP Technomed, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | high-intensity focused ultrasound ablation |
| Start date | Jul 1, 1999 |
| First posted | Feb 25, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: